2.6.1.5	2-aminooxyacetate	-	172051	
2.6.1.5	3,4-dihydroxyphenylalanine	-	1782	
2.6.1.5	3-(3,4-Dihydroxyphenyl)-2-methylalanine	-	29458	
2.6.1.5	3-methoxydopamine	-	91498	
2.6.1.5	3-Methoxytyrosine	-	43336	
2.6.1.5	Ag2+	-	1041	
2.6.1.5	alpha-Methyltyrosine	-	43749	
2.6.1.5	Ca2+	-	15	
2.6.1.5	Canaline	-	5532	
2.6.1.5	Hg2+	-	33	
2.6.1.5	homovanillic acid	-	12554	
2.6.1.5	L-glutamate	-	41	
2.6.1.5	Mn2+	-	11	
2.6.1.5	normetanephrine	-	7260	
2.6.1.5	Zn2+	-	14	
2.6.1.5	methiozolin	0.5 mM: 91% inhibition of enzyme activity, 0.25 mM: 57% inhibition of enzyme activity	172048	
2.6.1.5	cinmethylin	0.5 mM: 96% inhibition of enzyme activity, 0.25 mM: 20% inhibition of enzyme activity	172047	
2.6.1.5	EDTA	1 mM, 21% residual activity	21	
2.6.1.5	Aminooxyacetate	1 mM, complete inhibition	1374	
2.6.1.5	phenylhydrazine	1 mM, complete inhibition	398	
2.6.1.5	sodium dodecylsulfate	1 mM, complete inhibition	1066	
2.6.1.5	2-chloro-3-(5-{[(2,6-difluorobenzyl)oxy]methyl}-5-methyl-4,5-dihydro-1,2-oxazol-3-yl)-6-(propan-2-yl)pyridine	1 mM: 79% inhibition of enzyme activity, 0.5 mM: 67% inhibition of enzyme activity, 0.25 mM: 44% inhibition of enzyme activity	172050	
2.6.1.5	3-(5-{[(2,6-difluorobenzyl)oxy]methyl}-5-methyl-4,5-dihydro-1,2-oxazol-3-yl)pyridine-2-carbonitrile	1 mM: 82% inhibition of enzyme activity, 0.5 mM: 46% inhibition of enzyme activity, 0.25 mM: 8% inhibition of enzyme activity	172049	
2.6.1.5	AgNO3	10 mM, complete inhibition	360	
2.6.1.5	CuSO4	10 mM, complete inhibition	263	
2.6.1.5	kynuric acid	10 mM, complete inhibition	125165	
2.6.1.5	SnCl2	10 mM, complete inhibition	3228	
2.6.1.5	dopamine	100% inhibition with tyrosine at 3 mM and dopamine at 12 mM	242	
2.6.1.5	tyramine	13% inhibition with tyrosine at 3 mM and tyramine at 12 mM	280	
2.6.1.5	5-hydroxytryptophan	30% inhibition with tyrosine at 3 mM and 5-hydroxytryptophan at 12 mM	2540	
2.6.1.5	phenylacetic acid	30% inhibition with tyrosine at 3 mM and phenylacetic acid at 12 mM	960	
2.6.1.5	serotonin	37% inhibition with tyrosine at 3 mM and serotonin at 12 mM	437	
2.6.1.5	indole-3-acetic acid	42% inhibition with tyrosine at 3 mM and indole-3-acetic acid at 12 mM	2965	
2.6.1.5	Indole-3-propionic acid	48% inhibition with tyrosine at 3 mM and indole-3-propionic acid at 12 mM	6537	
2.6.1.5	vanillylmandelic acid	51% inhibition with tyrosine at 3 mM and vanillylmandelic acid at 3 mM	30503	
2.6.1.5	5-hydroxyindole acetic acid	55% inhibition with tyrosine at 3 mM and 5-hydroxyindole acetic acid at 12 mM	43544	
2.6.1.5	dihydroxymandelic acid	65% inhibition with tyrosine at 3 mM and dihydroxymandelic acid at 3 mM	93201	
2.6.1.5	indole-3-butyric acid	71% inhibition with tyrosine at 3 mM and indole-3-butyric acid at 12 mM	12559	
2.6.1.5	(4-hydroxyphenyl)acetic acid	74% inhibition with tyrosine at 3 mM and (4-hydroxyphenyl)acetic acid at 12 mM	10446	
2.6.1.5	Phenylethylamine	80% inhibition with tyrosine at 3 mM and phenylethylamine at 12 mM	900	
2.6.1.5	dihydroxyphenylacetic acid	88% inhibition with tyrosine at 3 mM and dihydroxyphenylacetic acid at 3 mM	29946	
2.6.1.5	D-tyrosine	9% inhibition with tyrosine at 3 mM and D-tyrosine at 12 mM	1643	
2.6.1.5	L-glutamate	competitive inhibition	41	
2.6.1.5	norepinephrine	competitive inhibition	975	
2.6.1.5	Dextran sulfate	dextran sulfate inhibits TAT activity but conditioned macrophage medium reliably increases enzyme activity in hepatocytes	2775	
2.6.1.5	2-oxoglutarate	enzyme shows substrate inhibition	34	
2.6.1.5	beta-phenylalanine	enzyme shows substrate inhibition	88728	
2.6.1.5	homogentisate	half-maximal inhibition with 15 micromolar	1826	
2.6.1.5	rosmarinic acid	isoenzymes TAT-2 and TAT-3	2035	
2.6.1.5	Aminooxyacetate	probably acts reacting with the cofactor	1374	
2.6.1.5	Canaline	probably acts reacting with the cofactor	5532	
2.6.1.5	4-methylsulfonyl-2,5,6,2',4'-pentachlorobiphenyl	significant reduction of dexamethasone-induced activity, 50% inhibition at 0.0007 mM	125166	
2.6.1.5	4-methylsulfonyl-2,5,6,2',4',5'-hexachlorobiphenyl	significant reduction of dexamethasone-induced activity, 50% inhibition at 0.0008 mM	125167	
2.6.1.5	ketoconazole	significant reduction of dexamethasone-induced activity, 50% inhibition at 0.0011 mM	483	
2.6.1.5	tolylfluanid	significant reduction of dexamethasone-induced activity, 50% inhibition at 0.0014 mM	125168	
2.6.1.5	3,4-Dihydroxyphenyllactate	strong inhibition of all the three TAT isoenzymes	20609	
2.6.1.5	2-oxoglutarate	substrate inhibition at high concentration	34	
2.6.1.5	Urea	the enzyme shows a gradual decrease in the activity till 2.5 M urea, after which the complete loss of activity is measured	116	
2.6.1.5	D-Aspartate	weak inhibition	634	
2.6.1.5	alpha-Methyl-L-aspartate	with L-tyrosine and 2-oxoglutarate or oxaloacetate as substrates	96130	
2.6.1.5	beta-Methyl-L-aspartate	with L-tyrosine and 2-oxoglutarate or oxaloacetate as substrates	92777	
2.6.1.5	L-aspartate	with L-tyrosine and 2-oxoglutarate or oxaloacetate as substrates	97